{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:42:27Z","timestamp":1787319747046,"version":"build-2736575974"},"reference-count":130,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T00:00:00Z","timestamp":1679443200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Czech Research Council","award":["NV19-03-00552"],"award-info":[{"award-number":["NV19-03-00552"]}]},{"name":"Czech Research Council","award":["MH CZ\u2013DRO-VFN64165"],"award-info":[{"award-number":["MH CZ\u2013DRO-VFN64165"]}]},{"name":"Ministry of Health, Czech Republic\u2014conceptual development of research organization","award":["NV19-03-00552"],"award-info":[{"award-number":["NV19-03-00552"]}]},{"name":"Ministry of Health, Czech Republic\u2014conceptual development of research organization","award":["MH CZ\u2013DRO-VFN64165"],"award-info":[{"award-number":["MH CZ\u2013DRO-VFN64165"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Maximal-effort upfront or interval debulking surgery is the recommended approach for advanced-stage ovarian cancer. The role of diagnostic imaging is to provide a systematic and structured report on tumour dissemination with emphasis on key sites for resectability. Imaging methods, such as pelvic and abdominal ultrasound, contrast-enhanced computed tomography, whole-body diffusion-weighted magnetic resonance imaging and positron emission tomography, yield high diagnostic performance for diagnosing bulky disease, but they are less accurate for depicting small-volume carcinomatosis, which may lead to unnecessary explorative laparotomies. Diagnostic laparoscopy, on the other hand, may directly visualize intraperitoneal involvement but has limitations in detecting tumours beyond the gastrosplenic ligament, in the lesser sac, mesenteric root or in the retroperitoneum. Laparoscopy has its place in combination with imaging in cases where ima-ging results regarding resectability are unclear. Different imaging models predicting tumour resectability have been developed as an adjunctional objective tool. Incorporating results from tumour quantitative analyses (e.g., radiomics), preoperative biopsies and biomarkers into predictive models may allow for more precise selection of patients eligible for extensive surgery. This review will discuss the ability of imaging and laparoscopy to predict non-resectable disease in patients with advanced ovarian cancer.<\/jats:p>","DOI":"10.3390\/cancers15061904","type":"journal-article","created":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T06:35:28Z","timestamp":1679466928000},"page":"1904","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Prediction of Surgical Outcome in Advanced Ovarian Cancer by Imaging and Laparoscopy: A Narrative Review"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6459-8529","authenticated-orcid":false,"given":"Patr\u00edcia","family":"Pinto","sequence":"first","affiliation":[{"name":"Department of Gynecology, Portuguese Institute of Oncology Francisco Gentil, 1099-023 Lisbon, Portugal"},{"name":"First Faculty of Medicine, Charles University and General University Hospital in Prague, 121 08 Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9975-2338","authenticated-orcid":false,"given":"Andrea","family":"Burgetova","sequence":"additional","affiliation":[{"name":"Department of Radiology, First Faculty of Medicine, Charles University and General University Hospital in Prague, 121 08 Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Cibula","sequence":"additional","affiliation":[{"name":"Gynecologic Oncology Center, Department of Obstetrics and Gynecology, First Faculty of Medicine, Charles University and General University Hospital in Prague, 121 08 Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingfrid S.","family":"Haldorsen","sequence":"additional","affiliation":[{"name":"Mohn Medical Imaging and Visualization Centre, Department of Radiology, Haukeland University Hospital, 5009 Bergen, Norway"},{"name":"Section of Radiology, Department of Clinical Medicine, University of Bergen, 5021 Bergen, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tereza","family":"Indrielle-Kelly","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Burton and Derby Hospitals NHS Trust, Derby DE13 0RB, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Fischerova","sequence":"additional","affiliation":[{"name":"Gynecologic Oncology Center, Department of Obstetrics and Gynecology, First Faculty of Medicine, Charles University and General University Hospital in Prague, 121 08 Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,3,22]]},"reference":[{"key":"ref_1","unstructured":"(2022, November 29). International Agency for Research on Cancer, 2018, W. GLOBOCAN 2018. Available online: http:\/\/globocan.iarc.fr\/."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.ejca.2012.12.027","article-title":"Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012","volume":"49","author":"Ferlay","year":"2013","journal-title":"Eur. J. Cancer"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1016\/S0140-6736(21)00731-5","article-title":"Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): A randomised controlled trial","volume":"397","author":"Menon","year":"2021","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1001\/jama.2011.766","article-title":"Effect of screening on ovarian cancer mortality: The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial","volume":"305","author":"Buys","year":"2011","journal-title":"JAMA"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ygyno.2016.08.334","article-title":"Extended mortality results for ovarian cancer screening in the PLCO trial with median 15 years follow-up","volume":"143","author":"Pinsky","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0140-6736(15)01224-6","article-title":"Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): A randomised controlled trial","volume":"387","author":"Jacobs","year":"2016","journal-title":"Lancet"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ygyno.2008.09.036","article-title":"Variations in institutional infrastructure, physician specialization and experience, and outcome in ovarian cancer: A systematic review","volume":"112","author":"Rochon","year":"2009","journal-title":"Gynecol. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.ygyno.2007.02.030","article-title":"The outcomes of ovarian cancer treatment are better when provided by gynecologic oncologists and in specialized hospitals: A systematic review","volume":"105","author":"Vernooij","year":"2007","journal-title":"Gynecol. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1097\/IGC.0000000000001041","article-title":"European Society of Gynaecological Oncology (ESGO) Guidelines for Ovarian Cancer Surgery","volume":"27","author":"Querleu","year":"2017","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1136\/ijgc-2020-001248","article-title":"Quality indicators for advanced ovarian cancer surgery from the European Society of Gynaecological Oncology (ESGO): 2020 update","volume":"30","author":"Fotopoulou","year":"2020","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1136\/ijgc-2021-002565","article-title":"ESGO\/ISUOG\/IOTA\/ESGE Consensus Statement on pre-operative diagnosis of ovarian tumors","volume":"31","author":"Timmerman","year":"2021","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Froyman, W., Wynants, L., Landolfo, C., Bourne, T., Valentin, L., Testa, A., Sladkevicius, P., Franchi, D., Fischerova, D., and Savelli, L. (2017). Validation of the Performance of International Ovarian Tumor Analysis (IOTA) Methods in the Diagnosis of Early Stage Ovarian Cancer in a Non-Screening Population. Diagnostics, 7.","DOI":"10.3390\/diagnostics7020032"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1200\/JCO.19.00022","article-title":"Role of Neoadjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer","volume":"37","author":"Baert","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/cncr.24149","article-title":"Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: By the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d\u2019Investigateurs Nationaux Pour les Etudes des Cancers de l\u2019Ovaire (GINECO)","volume":"115","author":"Reuss","year":"2009","journal-title":"Cancer"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/j.annonc.2020.08.2102","article-title":"ESMO recommendations on predictive biomarker testing for homologous recombination deficiency and PARP inhibitor benefit in ovarian cancer","volume":"31","author":"Miller","year":"2020","journal-title":"Ann. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1056\/NEJMoa1810858","article-title":"Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer","volume":"379","author":"Moore","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/S1470-2045(15)00086-8","article-title":"Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): Overall survival results of a phase 3 randomised trial","volume":"16","author":"Oza","year":"2015","journal-title":"Lancet Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1056\/NEJMoa1911361","article-title":"Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer","volume":"381","author":"Pautier","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1200\/JCO.19.01009","article-title":"Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer","volume":"37","author":"Tewari","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1200\/JCO.2002.20.5.1248","article-title":"Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: A meta-analysis","volume":"20","author":"Bristow","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S1470-2045(10)70292-8","article-title":"New terminology for cytoreduction in advanced ovarian cancer","volume":"12","author":"Zapardiel","year":"2011","journal-title":"Lancet Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1136\/ijgc-2019-000682","article-title":"TRUST: Trial of Radical Upfront Surgical Therapy in advanced ovarian cancer (ENGOT ov33\/AGO-OVAR OP7)","volume":"29","author":"Reuss","year":"2019","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/IGC.0b013e31823de6ae","article-title":"Prognostic value of residual tumor size in patients with epithelial ovarian cancer FIGO stages IIA-IV: Analysis of the OVCAD data","volume":"22","author":"Polterauer","year":"2012","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ygyno.2017.08.003","article-title":"Associations between residual disease and survival in epithelial ovarian cancer by histologic type","volume":"147","author":"Melamed","year":"2017","journal-title":"Gynecol. Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1038\/sj.bjc.6603116","article-title":"Clear cell carcinoma of the ovary: A retrospective multicentre experience of 254 patients with complete surgical staging","volume":"94","author":"Takano","year":"2006","journal-title":"Br. J. Cancer"},{"key":"ref_26","first-page":"A205","article-title":"186\u2005Surgical outcome as prognostic factor in different histologic subtypes of ovarian carcinoma-analysis of 7 phase III trials by AGO Studygroup + ENGOT","volume":"31","author":"Heitz","year":"2021","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ygyno.2017.02.023","article-title":"Optimal primary management of bulky stage IIIC ovarian, fallopian tube and peritoneal carcinoma: Are the only options complete gross resection at primary debulking surgery or neoadjuvant chemotherapy?","volume":"145","author":"Sioulas","year":"2017","journal-title":"Gynecol. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ygyno.2016.01.022","article-title":"Operability and chemotherapy responsiveness in advanced low-grade serous ovarian cancer. An analysis of the AGO Study Group metadatabase","volume":"140","author":"Grabowski","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/AOG.0b013e31829ce7ec","article-title":"Survival in women with grade 1 serous ovarian carcinoma","volume":"122","author":"Nickles","year":"2013","journal-title":"Obstet. Gynecol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ygyno.2018.06.020","article-title":"Neoadjuvant chemotherapy in elderly women with ovarian cancer: Rates of use and effectiveness","volume":"150","author":"Meyer","year":"2018","journal-title":"Gynecol. Oncol."},{"key":"ref_31","first-page":"672","article-title":"ESMO-ESGO consensus conference recommendations on ovarian cancer: Pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease","volume":"30","author":"Colombo","year":"2019","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"103","DOI":"10.5301\/tj.5000396","article-title":"FDG-PET\/CT to predict optimal primary cytoreductive surgery in patients with advanced ovarian cancer: Preliminary results","volume":"102","author":"Alessi","year":"2016","journal-title":"Tumori"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ejrad.2019.03.007","article-title":"MRI with diffusion-weighted imaging to predict feasibility of complete cytoreduction with the peritoneal cancer index (PCI) in advanced stage ovarian cancer patients","volume":"114","author":"Engbersen","year":"2019","journal-title":"Eur. J. Radiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1007\/s00330-013-2837-7","article-title":"Diffusion-weighted magnetic resonance imaging evaluation of intra-abdominal sites of implants to predict likelihood of suboptimal cytoreductive surgery in patients with ovarian carcinoma","volume":"23","author":"Espada","year":"2013","journal-title":"Eur. Radiol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.ygyno.2004.11.031","article-title":"Role of laparoscopy to assess the chance of optimal cytoreductive surgery in advanced ovarian cancer: A pilot study","volume":"96","author":"Fagotti","year":"2005","journal-title":"Gynecol. Oncol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ejca.2017.06.010","article-title":"Diagnostic value of whole body diffusion-weighted MRI compared to computed tomography for pre-operative assessment of patients suspected for ovarian cancer","volume":"83","author":"Michielsen","year":"2017","journal-title":"Eur. J. Cancer"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.ygyno.2016.08.322","article-title":"Correlation of pre-operative CT findings with surgical & histological tumor dissemination patterns at cytoreduction for primary advanced and relapsed epithelial ovarian cancer: A retrospective evaluation","volume":"143","author":"Nasser","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1148\/rg.326125511","article-title":"Ovarian carcinomatosis: How the radiologist can help plan the surgical approach","volume":"32","author":"Nougaret","year":"2012","journal-title":"Radiographics"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ygyno.2015.07.095","article-title":"Definition of a dynamic laparoscopic model for the prediction of incomplete cytoreduction in advanced epithelial ovarian cancer: Proof of a concept","volume":"139","author":"Petrillo","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ygyno.2017.02.020","article-title":"A multicenter assessment of the ability of preoperative computed tomography scan and CA-125 to predict gross residual disease at primary debulking for advanced epithelial ovarian cancer","volume":"145","author":"Suidan","year":"2017","journal-title":"Gynecol. Oncol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1200\/JCO.2016.69.7458","article-title":"How to Select Neoadjuvant Chemotherapy or Primary Debulking Surgery in Patients With Stage IIIC or IV Ovarian Carcinoma","volume":"34","author":"Vergote","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"983","DOI":"10.7150\/jca.32317","article-title":"Role of Laparotomy-based Parameters in Assessment of Optimal Primary Debulking Surgery and Long-term Outcomes in Patients with Stage IIIC Epithelial Ovarian Cancer","volume":"11","author":"Zhou","year":"2020","journal-title":"J. Cancer"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/cncr.20376","article-title":"The utility of computed tomography scans in predicting suboptimal cytoreductive surgery in women with advanced ovarian carcinoma","volume":"101","author":"Dowdy","year":"2004","journal-title":"Cancer"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.ygyno.2014.07.002","article-title":"A multicenter prospective trial evaluating the ability of preoperative computed tomography scan and serum CA-125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube, and peritoneal cancer","volume":"134","author":"Suidan","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1200\/JCO.2016.69.2962","article-title":"Laparoscopy to Predict the Result of Primary Cytoreductive Surgery in Patients With Advanced Ovarian Cancer: A Randomized Controlled Trial","volume":"35","author":"Rutten","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/1471-0528.12992","article-title":"Radiological predictors of cytoreductive outcomes in patients with advanced ovarian cancer","volume":"122","author":"Borley","year":"2015","journal-title":"BJOG"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1002\/1097-0142(20001001)89:7<1532::AID-CNCR17>3.0.CO;2-A","article-title":"A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography","volume":"89","author":"Bristow","year":"2000","journal-title":"Cancer"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.ygyno.2008.04.042","article-title":"External validation of a laparoscopic-based score to evaluate resectability of advanced ovarian cancers: Clues for a simplified score","volume":"110","author":"Brun","year":"2008","journal-title":"Gynecol. Oncol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1245\/ASO.2006.08.021","article-title":"A laparoscopy-based score to predict surgical outcome in patients with advanced ovarian carcinoma: A pilot study","volume":"13","author":"Fagotti","year":"2006","journal-title":"Ann. Surg. Oncol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1007\/s00330-010-1886-4","article-title":"ESUR guidelines: Ovarian cancer staging and follow-up","volume":"20","author":"Forstner","year":"2010","journal-title":"Eur. Radiol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1136\/ijgc-2018-000054","article-title":"Development of a preoperative computed tomography score for the management of advanced epithelial ovarian cancer","volume":"29","author":"Fuso","year":"2019","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ygyno.2007.11.002","article-title":"Prediction of suboptimal primary cytoreduction in primary ovarian cancer with combined positron emission tomography\/computed tomography--a prospective study","volume":"108","author":"Risum","year":"2008","journal-title":"Gynecol. Oncol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"108786","DOI":"10.1016\/j.ejrad.2019.108786","article-title":"Pre-operative evaluation of epithelial ovarian cancer patients: Role of whole body diffusion weighted imaging MR and CT scans in the selection of patients suitable for primary debulking surgery. A single-centre study","volume":"123","author":"Rizzo","year":"2020","journal-title":"Eur. J. Radiol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/RLU.0000000000000768","article-title":"Peritoneal carcinomatosis in primary ovarian cancer staging: Comparison between MDCT, MRI, and 18F-FDG PET\/CT","volume":"40","author":"Schmidt","year":"2015","journal-title":"Clin. Nucl. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/uog.10100","article-title":"Ultrasound evaluation of intra-abdominal sites of disease to predict likelihood of suboptimal cytoreduction in advanced ovarian cancer: A prospective study","volume":"39","author":"Testa","year":"2012","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1038\/sj.bjc.6605292","article-title":"Role of CT scan-based and clinical evaluation in the preoperative prediction of optimal cytoreduction in advanced ovarian cancer: A prospective trial","volume":"101","author":"Ferrandina","year":"2009","journal-title":"Br. J. Cancer."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1200\/JCO.1993.11.1.166","article-title":"Preoperative abdominopelvic computed tomographic prediction of optimal cytoreduction in epithelial ovarian carcinoma","volume":"11","author":"Nelson","year":"1993","journal-title":"J. Clin. Oncol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1177\/0284185116658683","article-title":"Preoperative prediction of suboptimal resection in advanced ovarian cancer based on clinical and CT parameters","volume":"58","author":"Son","year":"2017","journal-title":"Acta Radiol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ygyno.2014.11.004","article-title":"Nomogram for predicting incomplete cytoreduction in advanced ovarian cancer patients","volume":"136","author":"Shim","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejogrb.2016.10.034","article-title":"Imaging diagnostics in ovarian cancer: Magnetic resonance imaging and a scoring system guiding choice of primary treatment","volume":"210","author":"Kasper","year":"2017","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_61","first-page":"31","article-title":"OC11.01: Preoperative assessment of non-resectability in patients with ovarian cancer using imaging (ISAAC study): An interim analysis","volume":"60","author":"Pinto","year":"2022","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ygyno.2017.10.024","article-title":"Clinical significance of enlarged cardiophrenic lymph nodes in advanced ovarian cancer: Implications for survival","volume":"148","author":"Mert","year":"2018","journal-title":"Gynecol. Oncol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/s00261-021-03233-2","article-title":"Predictors of malignancy in incidental adnexal lesions identified on CT in patients with prior non-ovarian cancer","volume":"47","author":"Shinagare","year":"2022","journal-title":"Abdom. Radiol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.ygyno.2016.03.015","article-title":"Pattern of and reason for postoperative residual disease in patients with advanced ovarian cancer following upfront radical debulking surgery","volume":"141","author":"Heitz","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1016\/S1470-2045(18)30566-7","article-title":"Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: Pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials","volume":"19","author":"Vergote","year":"2018","journal-title":"Lancet Oncol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ygyno.2012.09.013","article-title":"Neoadjuvant chemotherapy in advanced ovarian cancer: On what do we agree and disagree?","volume":"128","author":"Vergote","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/978-1-4613-1247-5_23","article-title":"Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis","volume":"82","author":"Jacquet","year":"1996","journal-title":"Cancer Treat. Res."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"178.e1","DOI":"10.1016\/j.ajog.2009.10.856","article-title":"Comparison of peritoneal carcinomatosis scoring methods in predicting resectability and prognosis in advanced ovarian cancer","volume":"202","author":"Chereau","year":"2010","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1245\/s10434-014-4329-7","article-title":"Prognostic and Predictive Value of the Peritoneal Cancer Index in Primary Advanced Epithelial Ovarian Cancer Patients After Complete Cytoreductive Surgery: Study of Tumor Bank Ovarian Cancer","volume":"22","author":"Gasimli","year":"2015","journal-title":"Ann. Surg. Oncol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/IGC.0000000000000327","article-title":"Prognostic significance of Sugarbaker\u2019s peritoneal cancer index for the operability of ovarian carcinoma","volume":"25","author":"Lampe","year":"2015","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1097\/IGC.0b013e3182a616a7","article-title":"Accuracy and reproducibility of the peritoneal cancer index in advanced ovarian cancer during laparoscopy and laparotomy","volume":"23","author":"Gouy","year":"2013","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1097\/IGC.0000000000000767","article-title":"European Society of Gynaecologic Oncology Quality Indicators for Advanced Ovarian Cancer Surgery","volume":"26","author":"Querleu","year":"2016","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.acra.2019.04.005","article-title":"The accuracy of multi-detector computed tomography and laparoscopy in the prediction of peritoneal carcinomatosis index score in primary ovarian cancer","volume":"26","author":"Ahmed","year":"2019","journal-title":"Acad. Radiol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.3802\/jgo.2018.29.e65","article-title":"A triage strategy in advanced ovarian cancer management based on multiple predictive models for R0 resection: A prospective cohort study","volume":"29","author":"Feng","year":"2018","journal-title":"J. Gynecol. Oncol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"743","DOI":"10.21037\/qims.2020.02.19","article-title":"Preoperative PET\/CT score can predict complete resection in advanced epithelial ovarian cancer: A prospective study","volume":"10","author":"Gu","year":"2020","journal-title":"Quant. Imaging Med. Surg."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1245\/s10434-020-08649-6","article-title":"The Peritoneal Cancer Index is a Strong Predictor of Incomplete Cytoreductive Surgery in Ovarian Cancer","volume":"28","author":"Jonsdottir","year":"2021","journal-title":"Ann. Surg. Oncol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/IGC.0000000000001173","article-title":"Specific Regions, Rather than the Entire Peritoneal Carcinosis Index, are Predictive of Complete Resection and Survival in Advanced Epithelial Ovarian Cancer","volume":"28","author":"Rosendahl","year":"2018","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12957-018-1339-0","article-title":"Prediction of suboptimal cytoreductive surgery in patients with advanced ovarian cancer based on preoperative and intraoperative determination of the peritoneal carcinomatosis index","volume":"16","author":"Llueca","year":"2018","journal-title":"World J. Surg. Oncol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/uog.23654","article-title":"Preoperative staging of ovarian cancer: Comparison between ultrasound, CT and whole-body diffusion-weighted MRI (ISAAC study)","volume":"59","author":"Fischerova","year":"2022","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1200\/JCO.2006.07.7800","article-title":"Multi-institutional reciprocal validation study of computed tomography predictors of suboptimal primary cytoreduction in patients with advanced ovarian cancer","volume":"25","author":"Axtell","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"ref_81","first-page":"4043","article-title":"Nomogram for suboptimal cytoreduction at primary surgery for advanced stage ovarian cancer","volume":"31","author":"Gerestein","year":"2011","journal-title":"Anticancer Res."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ygyno.2015.04.013","article-title":"Development of a prediction model for residual disease in newly diagnosed advanced ovarian cancer","volume":"138","author":"Janco","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ygyno.2019.04.011","article-title":"Models to predict outcomes after primary debulking surgery: Independent validation of models to predict suboptimal cytoreduction and gross residual disease","volume":"154","author":"Kumar","year":"2019","journal-title":"Gynecol. Oncol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1007\/s11547-020-01170-6","article-title":"Radiological assessment of Peritoneal Cancer Index on preoperative CT in ovarian cancer is related to surgical outcome and survival","volume":"125","author":"Avesani","year":"2020","journal-title":"Radiol. Med."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13048-019-0488-2","article-title":"The ability of whole-body SUVmax in F-18 FDG PET\/CT to predict suboptimal cytoreduction during primary debulking surgery for advanced ovarian cancer","volume":"12","author":"Chong","year":"2019","journal-title":"J. Ovarian Res."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"642.e1","DOI":"10.1016\/j.ajog.2008.06.052","article-title":"Prospective validation of a laparoscopic predictive model for optimal cytoreduction in advanced ovarian carcinoma","volume":"199","author":"Fagotti","year":"2008","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.ejso.2013.03.022","article-title":"Diagnostic accuracy of hand-assisted laparoscopy in predicting resectability of peritoneal carcinomatosis from gynecological malignancies","volume":"39","author":"Varnoux","year":"2013","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"550","DOI":"10.4103\/ijc.IJC_306_17","article-title":"Role of laparoscopy in predicting surgical outcomes in patients undergoing interval cytoreduction surgery for advanced ovarian carcinoma: A prospective validation study","volume":"54","author":"Tomar","year":"2017","journal-title":"Indian J. Cancer"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13048-018-0415-y","article-title":"A predictive score for optimal cytoreduction at interval debulking surgery in epithelial ovarian cancer: A two- centers experience","volume":"11","author":"Ghisoni","year":"2018","journal-title":"J. Ovarian Res."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.ygyno.2018.10.017","article-title":"Concordance of a laparoscopic scoring algorithm with primary surgery findings in advanced stage ovarian cancer","volume":"151","author":"Hansen","year":"2018","journal-title":"Gynecol. Oncol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1007\/s00404-020-05874-y","article-title":"Concordance of laparoscopic and laparotomic peritoneal cancer index using a two-step surgical protocol to select patients for cytoreductive surgery in advanced ovarian cancer","volume":"303","author":"Angeles","year":"2021","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Climent, M.T., Serra, A., Gilabert-Estelles, J., Gilabert-Aguilar, J., and Llueca, A. (2021). Comparison of Peritoneal Carcinomatosis Scoring Methods in Predicting Resectability and Prognosis in Gynecologic Malignancies. J. Clin. Med., 10.","DOI":"10.3390\/jcm10122553"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"8111","DOI":"10.1038\/s41598-021-86928-2","article-title":"Validation of three predictive models for suboptimal cytoreductive surgery in advanced ovarian cancer","volume":"11","author":"Llueca","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11864-015-0379-8","article-title":"Current Recommendations for Minimally Invasive Surgical Staging in Ovarian Cancer","volume":"17","author":"Fagotti","year":"2016","journal-title":"Curr. Treat. Options Oncol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1006\/gyno.1998.5213","article-title":"Neoadjuvant chemotherapy or primary debulking surgery in advanced ovarian carcinoma: A retrospective analysis of 285 patients","volume":"71","author":"Vergote","year":"1998","journal-title":"Gynecol. Oncol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"462.e1","DOI":"10.1016\/j.ajog.2013.07.016","article-title":"A multicentric trial (Olympia-MITO 13) on the accuracy of laparoscopy to assess peritoneal spread in ovarian cancer","volume":"209","author":"Fagotti","year":"2013","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_97","first-page":"CD009786","article-title":"Laparoscopy for diagnosing resectability of disease in women with advanced ovarian cancer","volume":"3","author":"Rutten","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1016\/j.ejso.2021.05.019","article-title":"Peritoneal cancer index predicts severe complications after ovarian cancer surgery","volume":"47","author":"Lomnytska","year":"2021","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ejso.2017.11.003","article-title":"Prognostic value of peritoneal cancer index in primary advanced ovarian cancer","volume":"44","author":"Llueca","year":"2018","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1007\/s00261-016-0817-5","article-title":"Prediction of 5-year survival in advanced-stage ovarian cancer patients based on computed tomography peritoneal carcinomatosis index","volume":"41","author":"Fintelmann","year":"2016","journal-title":"Abdom. Radiol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13048-020-00625-8","article-title":"Ovarian cancer subtypes and survival in relation to three comprehensive imaging parameters","volume":"13","author":"Sartor","year":"2020","journal-title":"J. Ovarian. Res."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1136\/ijgc-2018-000066","article-title":"Pre-operative assessment of intra-abdominal disease spread in epithelial ovarian cancer: A comparative study between ultrasound and computed tomography","volume":"29","author":"Alcazar","year":"2019","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/uog.15942","article-title":"Ultrasound in preoperative assessment of pelvic and abdominal spread in patients with ovarian cancer: A prospective study","volume":"49","author":"Fischerova","year":"2017","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1148\/radiology.215.3.r00jn25761","article-title":"Staging of advanced ovarian cancer: Comparison of imaging modalities--report from the Radiological Diagnostic Oncology Group","volume":"215","author":"Tempany","year":"2000","journal-title":"Radiology"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/uog.14892","article-title":"Subjective ultrasound assessment, the ADNEX model and ultrasound-guided tru-cut biopsy to differentiate disseminated primary ovarian cancer from metastatic non-ovarian cancer","volume":"47","author":"Epstein","year":"2016","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/j.1525-1438.2007.01015.x","article-title":"Ultrasound-guided tru-cut biopsy in the management of advanced abdomino-pelvic tumors","volume":"18","author":"Fischerova","year":"2008","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/uog.8803","article-title":"Ultrasound-guided tru-cut biopsy of abdominal and pelvic tumors in gynecology","volume":"36","author":"Zikan","year":"2010","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Expert Panel on Women\u2019s Imaging, Kang, S.K., Reinhold, C., Atri, M., Benson, C.B., Bhosale, P.R., Jhingran, A., Lakhman, Y., Maturen, K.E., and Nicola, R. (2018). ACR Appropriateness Criteria((R)) Staging and Follow-Up of Ovarian Cancer. J. Am. Coll. Radiol., 15, S198\u2013S207.","DOI":"10.1016\/j.jacr.2018.03.015"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s00330-013-3083-8","article-title":"Whole-body MRI with diffusion-weighted sequence for staging of patients with suspected ovarian cancer: A clinical feasibility study in comparison to CT and FDG-PET\/CT","volume":"24","author":"Michielsen","year":"2014","journal-title":"Eur. Radiol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejrad.2010.11.039","article-title":"Ovarian Cancer Management: The role of imaging and diagnostic challenges","volume":"78","author":"Bharwani","year":"2011","journal-title":"Eur. J. Radiol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"108696","DOI":"10.1016\/j.ejrad.2019.108696","article-title":"Diffusion-weighted magnetic resonance imaging in peritoneal carcinomatosis from suspected ovarian cancer: Diagnostic performance in correlation with surgical findings","volume":"121","author":"Bhosale","year":"2019","journal-title":"Eur. J. Radiol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1007\/s00259-008-0890-2","article-title":"Diagnostic accuracy of integrated FDG-PET\/contrast-enhanced CT in staging ovarian cancer: Comparison with enhanced CT","volume":"35","author":"Kitajima","year":"2008","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ygyno.2013.08.023","article-title":"A prospective comparison of integrated FDG-PET\/contrast-enhanced CT and contrast-enhanced CT for pretreatment imaging of advanced epithelial ovarian cancer","volume":"131","author":"Hynninen","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.21037\/qims-20-784","article-title":"Diagnostic accuracy of (18)F-FDG PET\/CT scan for peritoneal metastases in advanced ovarian cancer","volume":"11","author":"Feng","year":"2021","journal-title":"Quant. Imaging Med. Surg."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","article-title":"Toxicity and response criteria of the Eastern Cooperative Oncology Group","volume":"5","author":"Oken","year":"1982","journal-title":"Am. J. Clin. Oncol."},{"key":"ref_116","unstructured":"American Society of Anesthesiologists (2022, November 29). ASA Physical Status Classification System. Available online: https:\/\/www.asahq.org\/standards-and-guidelines\/asa-physical-status-classification-system."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s40134-016-0157-9","article-title":"Update on Imaging of Ovarian Cancer","volume":"4","author":"Forstner","year":"2016","journal-title":"Curr. Radiol. Rep."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1053\/j.semnuclmed.2008.02.001","article-title":"Positron emission tomography\/magnetic resonance imaging: The next generation of multimodality imaging?","volume":"38","author":"Pichler","year":"2008","journal-title":"Semin. Nucl. Med."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"447","DOI":"10.2214\/AJR.10.4687","article-title":"Diagnosis of peritoneal dissemination: Comparison of 18F-FDG PET\/CT, diffusion-weighted MRI, and contrast-enhanced MDCT","volume":"196","author":"Satoh","year":"2011","journal-title":"AJR Am. J. Roentgenol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1148\/radiol.10100751","article-title":"Characterization of complex adnexal masses: Value of adding perfusion- and diffusion-weighted MR imaging to conventional MR imaging","volume":"258","author":"Toussaint","year":"2011","journal-title":"Radiology"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/CCO.0000000000000385","article-title":"Novel imaging techniques in gynaecological cancer","volume":"29","author":"Vandecaveye","year":"2017","journal-title":"Curr. Opin. Oncol."},{"key":"ref_122","first-page":"2333","article-title":"A meta-analysis on the diagnostic value of diffusion-weighted imaging on ovarian cancer","volume":"24","author":"Dai","year":"2019","journal-title":"J. BUON"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"70","DOI":"10.5334\/jbsr.1948","article-title":"Whole Body Diffusion-Weighted MRI in Ovarian Cancer Staging","volume":"103","author":"Vandecaveye","year":"2019","journal-title":"J. Belg. Soc. Radiol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.bpobgyn.2014.04.006","article-title":"Imaging techniques for the evaluation of ovarian cancer","volume":"28","author":"Fischerova","year":"2014","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1002\/ijc.20057","article-title":"Expression of GLUT-1 glucose transfer, cellular proliferation activity and grade of tumor correlate with [F-18]-fluorodeoxyglucose uptake by positron emission tomography in epithelial tumors of the ovary","volume":"109","author":"Kurokawa","year":"2004","journal-title":"Int. J. Cancer"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/IGC.0000000000000074","article-title":"Diagnostic value of preoperative SUVmax on FDG-PET\/CT for the detection of ovarian cancer","volume":"24","author":"Tanizaki","year":"2014","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.ygyno.2013.08.020","article-title":"PET\/CT in the staging of patients with a pelvic mass suspicious for ovarian cancer","volume":"131","author":"Dauwen","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ygyno.2009.10.059","article-title":"Diagnosis and staging of primary ovarian cancer: Correlation between PET\/CT, Doppler US, and CT or MRI","volume":"116","author":"Nam","year":"2010","journal-title":"Gynecol. Oncol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/MNM.0b013e3281afa256","article-title":"Diagnostic accuracy of 18F-FDG PET\/CT in characterizing ovarian lesions and staging ovarian cancer: Correlation with transvaginal ultrasonography, computed tomography, and histology","volume":"28","author":"Castellucci","year":"2007","journal-title":"Nucl. Med. Commun."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s00259-017-3638-z","article-title":"An update on the role of PET\/CT and PET\/MRI in ovarian cancer","volume":"44","author":"Khiewvan","year":"2017","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/15\/6\/1904\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:00:35Z","timestamp":1760122835000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/15\/6\/1904"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,22]]},"references-count":130,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,3]]}},"alternative-id":["cancers15061904"],"URL":"https:\/\/doi.org\/10.3390\/cancers15061904","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,22]]}}}